HMGN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.951800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.617900E-02
Normal-vs-Stage2
7.426000E-02
Normal-vs-Stage3
1.427560E-01
Normal-vs-Stage4
2.309500E-02
Stage1-vs-Stage2
8.577000E-01
Stage1-vs-Stage3
6.250200E-01
Stage1-vs-Stage4
2.717000E-01
Stage2-vs-Stage3
4.736800E-01
Stage2-vs-Stage4
3.072400E-01
Stage3-vs-Stage4
8.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.148400E-02
Normal-vs-AfricanAmerican
2.891800E-01
Normal-vs-Asian
1.323040E-01
Caucasian-vs-AfricanAmerican
4.946400E-01
Caucasian-vs-Asian
6.677000E-01
AfricanAmerican-vs-Asian
7.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.727900E-02
Normal-vs-Female
3.160500E-02
Male-vs-Female
5.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.413760E-01
Normal-vs-Age(41-60Yrs)
1.041610E-01
Normal-vs-Age(61-80Yrs)
5.200200E-02
Normal-vs-Age(81-100Yrs)
1.226270E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.068600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.427000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.417200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.101600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.835400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.282200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.712250E-01
Normal-vs-Daily Drinker
7.732000E-02
Normal-vs-Weekly Drinker
7.335500E-02
Normal-vs-Occasional Drinker
2.263600E-01
Normal-vs-Social Drinker
3.986300E-02
Non Drinker-vs-Daily Drinker
4.468600E-01
Non Drinker-vs-Weekly Drinker
6.450000E-01
Non Drinker-vs-Occasional Drinker
6.748400E-01
Non Drinker-vs-Social Drinker
8.878000E-01
Daily Drinker-vs-Weekly Drinker
8.253800E-01
Daily Drinker-vs-Occasional Drinker
2.690000E-01
Daily Drinker-vs-Social Drinker
5.414200E-01
Weekly Drinker-vs-Occasional Drinker
4.070600E-01
Weekly Drinker-vs-Social Drinker
7.062400E-01
Occasional Drinker-vs-Social Drinker
5.670400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.006600E-01
Normal-vs-Grade 2
7.653600E-02
Normal-vs-Grade 3
5.410200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.940400E-02
Grade 1-vs-Grade 3
3.761900E-02
Grade 1-vs-Grade 4
3.006600E-01
Grade 2-vs-Grade 3
9.721400E-01
Grade 2-vs-Grade 4
7.653600E-02
Grade 3-vs-Grade 4
5.410200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.708000E-02
Normal-vs-NonDiabetic
6.217700E-02
Diabetic-vs-NonDiabetic
3.415400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.228400E-01
Normal-vs-NoPancreatitis
6.101600E-02
Pancreatitis-vs-NoPancreatitis
6.077600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.002760E-01
Normal-vs-N1
5.386200E-02
N0-vs-N1
3.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.955200E-01
Normal-vs-TP53-NonMutant
1.942810E-01
TP53-Mutant-vs-TP53-NonMutant
1.024240E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
